Skip to main content
Have a personal or library account? Click to login
Advances in the management of craniopharyngioma in children and adults Cover

Advances in the management of craniopharyngioma in children and adults

Open Access
|Oct 2019

Figures & Tables

Figure 1

Large, partially solid, partially multicystic adamantinomatous craniopharyngioma in a 5-year old boy. (A) Coronal T2 sequence through sellar region; solid part of the tumor (white arrow) involves enlarged sella turcica, parasellar regions, occupies the suprasellar cistern and the third ventricle. The cystic portion of the tumor (black arrow) extends into the lateral ventricles and on the right side it infiltrates the adjacent brain parenchym (small arrow). Lateral ventricles are enlarged with a band of periventricular transependimal edema as a sign of acute hydrocephalus. (B) Sagital T2 sequence through the sellar region; Hypothalamus and mammillary bodies are not visible (arrow). (C) SWI sequence through the multicystic portion of the tumor shows multiple calcifications in the cyst walls (arrow).

Table 1

Comparison of pediatric and adult-onset craniopharyngioma characteristics

Pediatric-onsetAdult-onset
30–50 % of all CPs
Age at presentationPeak at 5–14 years1Peak at 40–44 years2
Gender distribution (m/f)Equal8,21Equal8,27
Most frequent presentationHeadache (68–85%)Visual impairment (40–84%)
Visual impairment (36– 55%)Menstrual irregularities (57%)
Growth failure (7–36%)9,35,66Headache (42–56%)13,26,27
Pathohistological typeAdamantinomatous 99%33
Papillary extremely rare*Papillary 14–50%
Initial hypothalamic involvement42–66%8,9,3542%18
Endocrine deficits at diagnosis
Any40–87%8,13,21,35,65,6641–73%8
GH41–75%8,13,21,35,65,6618–86%8,13
FSH/LH20–56%8,13,21,35,65,6629–74%8,13
ACTH8–68%8,13,21,35,65,6635–58%8,13
TSH15–32%8,13,21,35,65,6635–56%8,13
ADH7–17%8,13,21,35,65,666–17%8,13
Pituitary hormone deficiencies after treatment
Any64–100%8,6448–97%8,64
GH93–96%8,18,2152–68%8,18
FSH/LH59–95%8,18,2170–94%8,18
ACTH78–100%8,18,2174–88%8,18
TSH86–100%8,18,2181–92%8,18
ADH65–96%8,18,2143–70%8,18
Panhypopituitarism***43–100%8,18,6459–74%8,18,64
Obesity**44–64%8,9,19,6441–47%8,19,64

[i] * Only 23 identified cases since 1995.83

** Obesity was defined with BMI > 30 kg/m2 in adults and BMI >95. percentile for their age in children.

*** Panhypopituitarism was defined as present when 3 anterior pituitary deficiencies were diagnosed in one patient (growth hormone deficiency, thyroid-stimulating hormone deficiency, adrenocorticotropic hormone deficiency, and late puberty in children or hypogonadism in adults).

ACTH = adrenocorticotropic hormone; ADH = vasopressin (antidiuretic hormone); FSH/LH = follicle stimulating hormone/luteinizing hormone; GH = growth hormone; TSH = thyroid stimulating hormone

DOI: https://doi.org/10.2478/raon-2019-0036 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 388 - 396
Submitted on: Jun 21, 2019
Accepted on: Jul 11, 2019
Published on: Oct 25, 2019
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Mojca Jensterle, Soncka Jazbinsek, Roman Bosnjak, Mara Popovic, Lorna Zadravec Zaletel, Tina Vipotnik Vesnaver, Barbara Faganel Kotnik, Primoz Kotnik, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.